Gastroesophageal Reflux Disease (GERD) Therapeutics Market Report

Global and Region Gastroesophageal Reflux Disease (GERD) Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：171
  • REPORT CODE：GMM886802
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Gastroesophageal Reflux Disease (GERD) Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Gastroesophageal Reflux Disease (GERD) Therapeuticsmarket, defines the market attractiveness level of Gastroesophageal Reflux Disease (GERD) Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Gastroesophageal Reflux Disease (GERD) Therapeutics industry, describes the types of Gastroesophageal Reflux Disease (GERD) Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastroesophageal Reflux Disease (GERD) Therapeutics market and the development prospects and opportunities of Gastroesophageal Reflux Disease (GERD) Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastroesophageal Reflux Disease (GERD) Therapeutics market in Chapter 13.

    By Player:

    • Eisai

    • Takeda

    • Johnson & Johnson

    • AstraZeneca

    • GSK

    By Type:

    • Antacids

    • Pro-kinetic agents

    • H2 Receptor Blockers

    • Proton Pump Inhibitors (PPIs)

    By End-User:

    • Heartburn

    • Acid reflux disorders

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Gastroesophageal Reflux Disease (GERD) Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Gastroesophageal Reflux Disease (GERD) Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption (2017-2022)

    • 7.2 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption (2017-2022)

    • 7.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption (2017-2022)

    • 7.4 China Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption (2017-2022)

    • 7.5 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption (2017-2022)

    • 7.6 India Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Gastroesophageal Reflux Disease (GERD) Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast (2022-2028)

    9 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Antacids Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pro-kinetic agents Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global H2 Receptor Blockers Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Proton Pump Inhibitors (PPIs) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Heartburn Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Acid reflux disorders Consumption and Growth Rate (2017-2022)

    10 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Antacids Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Pro-kinetic agents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global H2 Receptor Blockers Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Proton Pump Inhibitors (PPIs) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Heartburn Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Acid reflux disorders Consumption Forecast and Growth Rate (2022-2028)

    11 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Gastroesophageal Reflux Disease (GERD) Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Competitive Analysis

    • 14.1 Eisai

      • 14.1.1 Eisai Company Details

      • 14.1.2 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    • 14.2 Takeda

      • 14.2.1 Takeda Company Details

      • 14.2.2 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    • 14.3 Johnson & Johnson

      • 14.3.1 Johnson & Johnson Company Details

      • 14.3.2 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    • 14.4 AstraZeneca

      • 14.4.1 AstraZeneca Company Details

      • 14.4.2 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    • 14.5 GSK

      • 14.5.1 GSK Company Details

      • 14.5.2 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Gastroesophageal Reflux Disease (GERD) Therapeutics

    • Figure Gastroesophageal Reflux Disease (GERD) Therapeutics Picture

    • Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption by Country (2017-2022)

    • Figure United States Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Gastroesophageal Reflux Disease (GERD) Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antacids Consumption and Growth Rate (2017-2022)

    • Figure Global Pro-kinetic agents Consumption and Growth Rate (2017-2022)

    • Figure Global H2 Receptor Blockers Consumption and Growth Rate (2017-2022)

    • Figure Global Proton Pump Inhibitors (PPIs) Consumption and Growth Rate (2017-2022)

    • Figure Global Heartburn Consumption and Growth Rate (2017-2022)

    • Figure Global Acid reflux disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Antacids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pro-kinetic agents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global H2 Receptor Blockers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Proton Pump Inhibitors (PPIs) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Heartburn Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acid reflux disorders Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Gastroesophageal Reflux Disease (GERD) Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Gastroesophageal Reflux Disease (GERD) Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US